Flow cytometry analysis illustrated significantly higher proportions of CCR6+ (C) (P = 0.0061) and CXCR3+ (E) (P = 0.0114) T cells in anti-DNA+ SLE patients in comparison to anti-DNA− SLE patients. This evidence concerns the gene CCR6 and systemic lupus erythematosus.